skip to Main Content

EVENT BIO

See breakdown of all you need to know about our Summit

HOT CONFERENCE TOPICS

  • Challenges in R&D Data Management
  • Current achievement and (near-)future promise of AI in drug discovery
  • Targeting protein-protein interactions with small molecule drugs
  • Machine-Learning Models for Predicting Frequent Hitter Behavior of Small Molecules
  • Industry-Academia Collaborations – Opportunities and things to consider
  • Antibody-enabled small molecule drug discovery
  • Finding a needle in the haystack via High-Throughput screening approach
  • How to overcome the R&D Productivity killers?
  • The challenges and promise of cancer immunotherapy – Next-generation immune therapies

WHO WILL YOU MEET

Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors, QPPVs, and Heads of departments from pharmaceutical industry / industries involved in:

  • R&D
  • Drug Discovery
  • Drug Development
  • Computational Biology and Chemistry
  • Antibody discovery
  • Medicinal chemistry
  • Bioinformatics
  • Open Innovation
  • Data Science
  • High Throughput Screening
  • Early research and development
  • Innovation
  • External Innovation
  • Scientific Partnerships
  • Artificial Intelligence
  • Machine Learning
  • Translational Medicine
  • R&D Information Technology
  • R&D Analytics
  • New Technology
  • Immunology
  • In vivo, In vitro, In silico

Workshop A
26 March 2019 I 15.00 – 16.00

Big Data in R&D

  • The pharmaceutical R&D process and the inherent data challenge
  • How to handle and process the voluminous data
  • How to keep data “safe” in scientific collaboration and partnerships?
  • The current regulatory environment and access to real world data
  • Boosting the R&D productivity with the RWE model

Workshop B
26 March
 2019 I 16.00 – 17.00

Trends in drug discovery technology

  • How to identify compounds and candidate drugs with ‘good’ properties that are safe and efficacious as quickly and cheaply as possible?
  • Innovations in High Throughput Screening – are there any?
  • The potential of Next-generation sequencing in personalised medicine
  • Label-free technologies in drug discovery
  • Phenotypic screening and the usage in drug discovery
  • How to shift the emphasis in medicine from reaction to prevention?

WHAT DELEGATES SAID

2nd Annual Pharma 2020: The Future of R&D Summit
TIME IS RUNNING OUT! DON’T RISK MISSING IT
Back To Top